Both MMP-2 and MMP-9 have been extensively studied as biomarkers and therapeutic targets in different types of cancers (Zhang et al., 2008; Roy et al., 2009; Oguić et al., 2014; Webb et al., 2017; Wang et al., 2019). This evidence concerns the gene MMP2 and cancer.